HCP Live

NCCN 2010: Dr. Len Saltz, Memorial Sloan-Kettering Cancer Center

Mar 17, 2010

Leonard Saltz, MD of the Memorial Sloan-Kettering Cancer Center speaks about New Therapies for Neuroendocrine Tumors at the 15th Annual NCCN Conference in Hollywood, FL March, 2010.

Related Videos

Victor Kim, MD: Addressing Comorbidities and Advancing COPD Care

Victor-Kim-MD

Cedric Rutland, MD: Exploring Immunology's Role in Molecule Development

Panagis Galiatsatos, MD: Closing the Gap in Lung Cancer Screening

Antonio Anzueto, MD: Advancing Triple-Therapy Inhalers for COPD

Panagis Galiatsatos, MD

Cedric Rutland, MD: Mechanisms Behind Immunology, Cellular Communication

Related Content

Psoriatic Arthritis Linked to Increased Vascular Inflammation, Regardless of Disease Activity

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Report: For US Patients, Gout Burden Greatest Among Asian Americans

BE VITAL: Bimekizumab Helps Control, Attenuate Disease Activity in Psoriatic Arthritis

Psoriatic Arthritis Linked to Increased Vascular Inflammation, Regardless of Disease Activity

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Report: For US Patients, Gout Burden Greatest Among Asian Americans

BE VITAL: Bimekizumab Helps Control, Attenuate Disease Activity in Psoriatic Arthritis

Psoriatic Arthritis Linked to Increased Vascular Inflammation, Regardless of Disease Activity

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Report: For US Patients, Gout Burden Greatest Among Asian Americans

BE VITAL: Bimekizumab Helps Control, Attenuate Disease Activity in Psoriatic Arthritis

Related Content

Nienke Kleinrensink, MSc | Credit: LinkedIn

Psoriatic Arthritis Linked to Increased Vascular Inflammation, Regardless of Disease Activity

Live From ATS 2023 with Anne Dixon, MD

Lungcast: Live From ATS 2023 with Anne Dixon, MD

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

New Insight: A Look at Avacincaptad Pegol with Pravin Dugel, MD

April 23rd 2023

Natalie McCormick, PhD | Credit: LinkedIn

Report: For US Patients, Gout Burden Greatest Among Asian Americans

Professor Ian McInnes | Credit: University of Glasgow

BE VITAL: Bimekizumab Helps Control, Attenuate Disease Activity in Psoriatic Arthritis

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.